2022. Safety profile and adverse drug reactions with causality assessment of Ticagrelor in Myocardial Infraction. Journal of Pharmacovigilance and Drug Research. 3, 2 (Jun. 2022), 41–45. DOI:https://doi.org/10.53411/jpadr.2022.3.2.9.